However, after replacing the growth media with a medium with different CCL21/IL1β protein treatments, the purified protein extract from transgenic leaves and the commercial protein remarkably prevented the migration and growth of cancer cell lines in monolayer cell cultures compared to control groups (basal medium and non-recombinant protein). The gene discussed is IL1B; the disease is cancer.